Home › Funds › Aristotle Atlantic Partners, LLC › TECH
Aristotle Atlantic Partners, LLC position in TECH
BIO-TECHNE CORP · Health Care
Aristotle Atlantic Partners, LLC reported holding 273,314 shares of TECH (BIO-TECHNE CORP) in its Q3 2026 13F filing — a position valued at US$19.8M, representing 0.77% of its reported portfolio and ranking #44 among its reported holdings. Aristotle Atlantic Partners, LLC has disclosed TECH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Aristotle Atlantic Partners, LLC's TECH position evolved
Aristotle Atlantic Partners, LLC first disclosed a stake in TECH in Q3 2023 at 653,635 shares (US$44.5M). The position peaked in Q3 2024 at 785,504 shares, worth US$62.8M. Across 13 filings, Aristotle Atlantic Partners, LLC increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 273,314 shares valued at US$19.8M — a reduction of -386,223 shares quarter over quarter.. Notable position changes include a 28% increase in Q1 2025 (shares fell 12% over the following quarter), a 38% trim in Q4 2025 (shares fell 11% over the following quarter), a 59% trim in Q3 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 653.63K | $44.49M | New |
| Q4 2023 | 759.41K | $58.60M | Add |
| Q1 2024 | 735.76K | $51.79M | Reduce |
| Q2 2024 | 721.67K | $51.71M | Reduce |
| Q3 2024 | 785.50K | $62.79M | Add |
| Q4 2024 | 754.36K | $54.34M | Reduce |
| Q1 2025 | 966.37K | $56.66M | Add |
| Q2 2025 | 1.05M | $54.14M | Add |
| Q3 2025 | 1.03M | $57.15M | Reduce |
| Q4 2025 | 636.82K | $37.45M | Reduce |
| Q1 2026 | 612.83K | $32.03M | Reduce |
| Q2 2026 | 659.54K | $46.60M | Add |
| Q3 2026 | 273.31K | $19.81M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TECH and 13F data
TECH (BIO-TECHNE CORP) is a Health Care company. 24 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$560.3M), Ruane Cunniff & Goldfarb (Sequoia) (US$242.3M), Qube Research & Technologies Ltd (US$172.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TECH
- HBK INVESTMENTS L P 7.73M sh · $560.35M · Q3 2026
- Ruane Cunniff & Goldfarb (Sequoia) 3.34M sh · $242.26M · Q3 2026
- Qube Research & Technologies Ltd 2.38M sh · $172.44M · Q3 2026
- WHITEBOX ADVISORS LLC 2.10M sh · $148.37M · Q2 2026
- RGM Capital, LLC 2.15M sh · $126.56M · Q4 2025
More on Aristotle Atlantic Partners, LLC
FAQ
How long has Aristotle Atlantic Partners, LLC held TECH?
Aristotle Atlantic Partners, LLC has disclosed TECH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Aristotle Atlantic Partners, LLC's current position in TECH?
As of Q3 2026, Aristotle Atlantic Partners, LLC holds 273.31K shares of TECH (BIO-TECHNE CORP), valued at $19.81M, representing 0.77% of its reported portfolio and ranking #44.
Has Aristotle Atlantic Partners, LLC been buying or selling TECH?
In the latest 13F filing (Q3 2026), Aristotle Atlantic Partners, LLC reduced its position in TECH. The position peaked in Q3 2024 at 785.50K shares.
Which other funds hold TECH?
Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), Qube Research & Technologies Ltd, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.